An update from Shionogi & Co ( ($JP:4507) ) is now available. Shionogi & Co. has announced that its new drug application for ensitrelvir fumaric ...

The proportion of “national blood” in domestic blood-derived products would be ratcheted up over the next few years to reduce dependence on foreign sources and reinforce Taiwan’s medical resilience, ...